Published in Eur J Haematol on December 10, 2007
Molecular determinants of human T-lymphotropic virus type 1 transmission and spread. Viruses (2011) 0.92
Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia. Blood (2013) 0.90
Zidovudine and Lamivudine for HIV Infection. Clin Med Rev Ther (2010) 0.89
Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma. Vet Pathol (2010) 0.88
Clonal structure of rapid-onset MDV-driven CD4+ lymphomas and responding CD8+ T cells. PLoS Pathog (2011) 0.81
Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies. Blood Cancer J (2012) 0.80
Schedule-dependent inhibition of T-cell lymphoma cells by cotreatment with the mTOR inhibitor everolimus and anticancer drugs. Invest New Drugs (2010) 0.78
Rapidly fatal HTLV-1-associated T-cell leukemia/lymphoma in a patient with SLE. Nat Rev Rheumatol (2009) 0.77
A comparative study of HIV-1 and HTLV-I protease structure and dynamics reveals a conserved residue interaction network. J Mol Model (2011) 0.76
An update on the management of peripheral T-cell lymphoma and emerging treatment options. J Blood Med (2011) 0.76
Differential role of PKC-induced c-Jun in HTLV-1 LTR activation by 12-O-tetradecanoylphorbol-13-acetate in different human T-cell lines. PLoS One (2012) 0.76
Cutaneous papules, hypercalcemia, and osteolytic bone lesions. Mayo Clin Proc (2011) 0.75
Adult T-Cell Leukemia/Lymphoma with CLL-Like Morphology-A Case Report. Case Rep Med (2010) 0.75
Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology (2002) 2.71
Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol (2010) 2.64
Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. J Clin Oncol (2006) 2.53
VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol (2007) 1.79
Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma. J Clin Oncol (2012) 1.62
Epstein-Barr virus genome level, T-cell clonality and the prognosis of angioimmunoblastic T-cell lymphoma. Haematologica (2005) 1.52
Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma. J Clin Oncol (2014) 1.39
Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively. Immunogenetics (2002) 1.25
Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis. Blood (2005) 1.23
Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era. Cancer Sci (2009) 1.22
Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era. Cancer (2011) 1.13
Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas. J Pathol (2004) 1.10
Germline mutations of the MYH gene in Japanese patients with multiple colorectal adenomas. Mutat Res (2005) 1.08
Attenuated antibody reaction for the primary antigen but not for the recall antigen of influenza vaccination in patients with non-Hodgkin B-cell lymphoma after the administration of rituximab-CHOP. J Clin Exp Hematop (2009) 1.05
Surgical management of adult sigmoid colon intussusception caused by a malignant tumor: report of a case. Surg Today (2003) 1.01
Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era. Cancer Sci (2011) 1.00
Imatinib mesylate inhibits cell invasion of malignant peripheral nerve sheath tumor induced by platelet-derived growth factor-BB. Lab Invest (2007) 0.99
Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma. Leuk Lymphoma (2009) 0.98
Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathway. Oncogene (2005) 0.97
A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan. Int J Clin Oncol (2004) 0.96
p38 mitogen-activated protein kinase inhibitor LY2228820 enhances bortezomib-induced cytotoxicity and inhibits osteoclastogenesis in multiple myeloma; therapeutic implications. Br J Haematol (2008) 0.96
Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults. Int J Oncol (2004) 0.92
Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy. Support Care Cancer (2015) 0.92
Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A). Br J Haematol (2014) 0.91
Vancomycin bactericidal activity as a predictor of 30-day mortality in patients with methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother (2011) 0.91
Pleural malignant mesothelioma with invasive micropapillary component and its association with pulmonary metastasis. Pathol Int (2009) 0.89
Therapeutic potential of arsenic trioxide with or without interferon-alpha for relapsed/refractory adult T-cell leukemia/lymphoma. Haematologica (2007) 0.87
Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: in vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737. Cancer Lett (2011) 0.87
Coexistent anaplastic and differentiated thyroid carcinoma: an immunohistochemical study. Am J Clin Pathol (2006) 0.86
Safety and pharmacokinetic evaluation of repeated intravenous administration of palonosetron 0.75 mg in patients receiving highly or moderately emetogenic chemotherapy. Support Care Cancer (2014) 0.86
First reported case of hemoglobin lansing in Asia detected by false low oxygen saturation on pulse oximetry. Int J Hematol (2012) 0.85
Targeting CD56 by the maytansinoid immunoconjugate IMGN901 (huN901-DM1): a potential therapeutic modality implication against natural killer/T cell malignancy. Br J Haematol (2008) 0.83
Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever. Int J Antimicrob Agents (2005) 0.83
Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection. Scand J Infect Dis (2012) 0.83
Smouldering adult T-cell leukaemia/lymphoma: a follow-up study in Kyushu. Br J Haematol (2008) 0.82
Beta-cell function is a major contributor to oral glucose disposition in obese Japanese students. Endocr J (2007) 0.82
Birt-Hogg-Dubé syndrome and familial adenomatous polyposis: an association or a coincidence? Intern Med (2012) 0.82
Determination of splice-site mutations in Lynch syndrome (hereditary non-polyposis colorectal cancer) patients using functional splicing assay. Fam Cancer (2009) 0.82
Osteosarcoma of the patella mimicking giant cell tumor: imaging features with histopathological correlation. Anticancer Res (2014) 0.82
Administration of chemotherapy via the median cubital vein without implantable central venous access ports: port-free chemotherapy for metastatic colorectal cancer patients. Int J Clin Oncol (2014) 0.81
THP-COP regimen for the treatment of peripheral T-cell lymphoma and adult T-cell leukemia/lymphoma: a multicenter phase II study. Eur J Haematol (2010) 0.81
Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in Japan. Anticancer Res (2009) 0.81
Oncogene associated cDNA microarray analysis shows PRAME gene expression is a marker for response to anthracycline containing chemotherapy in patients with diffuse large B-cell lymphoma. J Clin Exp Hematop (2009) 0.81
Rapid and sensitive HPLC method for the simultaneous determination of paraquat and diquat in human serum. Anal Sci (2007) 0.81
Antitumor effects of CRM197, a specific inhibitor of HB-EGF, in T-cell acute lymphoblastic leukemia. Anticancer Res (2011) 0.81
Population pharmacokinetic study of a test dose oral busulfan in Japanese adult patients undergoing hematopoietic stem cell transplantation. Cancer Chemother Pharmacol (2010) 0.80
Primary colorectal T-cell lymphoma. J Gastroenterol (2003) 0.80
A patient with acute myeloid leukemia who developed fatal pneumonia caused by carbapenem-resistant Bacillus cereus. J Infect Chemother (2009) 0.80
Phase II study of cladribine (2-chlorodeoxyadenosine) in relapsed or refractory adult T-cell leukemia-lymphoma. Int J Hematol (2003) 0.80
Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan: a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group. Int J Hematol (2010) 0.80
Dose response of pegfilgrastim in Japanese breast cancer patients receiving six cycles of docetaxel, doxorubicin, and cyclophosphamide therapy: a randomized controlled trial. Support Care Cancer (2015) 0.79
Cladribine treatment in two-hour intravenous infusion for previously-treated low grade B-cell lymphoma: a pilot study. J Clin Exp Hematop (2009) 0.79
The prophylactic effect of itraconazole capsules and fluconazole capsules for systemic fungal infections in patients with acute myeloid leukemia and myelodysplastic syndromes: a Japanese multicenter randomized, controlled study. Int J Hematol (2007) 0.79
Desmoplastic small round cell tumors in a young man. Intern Med (2013) 0.79
RARalpha is a regulatory factor for Am-80-induced cell growth inhibition of hematologic malignant cells. Int J Oncol (2007) 0.79
[High dose ara-C therapy induced bradycardia in an acute myeloid leukemia patient with inv (16)(p13q22)]. Rinsho Ketsueki (2003) 0.79
Mucinous carcinoma of the duodenum associated with hereditary nonpolyposis colorectal cancer: report of a case. Surg Today (2006) 0.79
Mature T/NK-cell lymphoproliferative disease and Epstein-Barr virus infection are more frequent in patients with rheumatoid arthritis treated with methotrexate. Virchows Arch (2013) 0.79
Disturbance of the growth hormone-insulin-like growth factor-1 axis associated with poor performance status in patients with solid tumors. Jpn J Clin Oncol (2009) 0.78
Bortezomib, doxorubicin and intermediate-dose dexamethasone (iPAD) therapy for relapsed or refractory multiple myeloma: a multicenter phase 2 study. Int J Hematol (2013) 0.77
Alterations of the base excision repair gene MUTYH in sporadic colorectal cancer. Oncol Rep (2012) 0.77
Efficacy and safety of micafungin as an empirical antifungal therapy for suspected fungal infection in neutropenic patients with hematological disorders. Ann Hematol (2011) 0.77
Dosage of capecitabine and cyclophosphamide combination therapy in patients with metastatic breast cancer. Anticancer Res (2007) 0.77
[A novel genetic disorder of Lynch syndrome - EPCAM gene deletion]. Gan To Kagaku Ryoho (2013) 0.77
Screening of promising chemotherapeutic candidates from plants against human adult T-cell leukemia/lymphoma (IV): phenanthroindolizidine alkaloids from Tylophora tanakae leaves. J Nat Med (2015) 0.77
A phase I study of bortezomib in combination with doxorubicin and intermediate-dose dexamethasone (iPAD therapy) for relapsed or refractory multiple myeloma. Int J Hematol (2010) 0.77
Serum vitamin C levels in type 2 diabetic nephropathy. Diabetes Care (2005) 0.76
Prospective randomized study of cefepime, panipenem, or meropenem monotherapy for patients with hematological disorders and febrile neutropenia. J Infect Chemother (2012) 0.76
Am80 inhibits stromal cell-derived factor-1-induced chemotaxis in T-cell acute lymphoblastic leukemia cells. Leuk Lymphoma (2010) 0.76
Expression and role of GLUT-1, MCT-1, and MCT-4 in malignant pleural mesothelioma. Virchows Arch (2012) 0.76
Neoadjuvant epirubicin/docetaxel (ET) concomitant chemotherapy for primary breast cancer with tumor diameter >=3.1 cm: results of the Kyushu ET therapy phase II trial. Anticancer Res (2012) 0.76
Docetaxel/irinotecan combination chemotherapy in platinum/taxane-refractory and -resistant ovarian cancer: JGOG/WJGOG Intergroup Study. Int J Clin Oncol (2011) 0.76
An evaluation of busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation. Jpn J Clin Oncol (2005) 0.76
Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: a phase II study. Anticancer Drugs (2010) 0.76
[Extranodal NK/T-cell lymphoma arising from soft tissue of the left forearm]. Rinsho Ketsueki (2010) 0.76
Interferon-α and zidovudine for relapsed/refractory adult T cell leukemia/lymphoma: case reports of Japanese patients. Int J Hematol (2010) 0.76
Methicillin-resistant Staphylococcus aureus bloodstream infections in a Japanese University Hospital between 1987 and 2004. J Infect Chemother (2011) 0.76
Evaluation of regional cerebral glucose metabolism in patients with malignant lymphoma of the body using statistical image analysis. Ann Nucl Med (2014) 0.76
Importance of inducible multidrug resistance 1 expression in HL-60 cells resistant to gemtuzumab ozogamicin. Leuk Lymphoma (2012) 0.76
Screening of promising chemotherapeutic candidates from plants against human adult T-cell leukemia/lymphoma (III). J Nat Med (2013) 0.76
Simple and sensitive HPLC method for the fluorometric determination of methotrexate and its major metabolites in human plasma by post-column photochemical reaction. Biomed Chromatogr (2011) 0.75
Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in Japan. J Infect Chemother (2013) 0.75
[A study of the sialogogic effect of cevimeline gargle]. Gan To Kagaku Ryoho (2013) 0.75
[A phase III study of the efficacy and safety of meropenem in patients with febrile neutropenia]. Jpn J Antibiot (2012) 0.75
Pregnancy complicated with pure red cell aplasia: a case report. J Perinat Med (2003) 0.75
[Side effects of chemotherapy]. Nihon Rinsho (2015) 0.75
Development of an integrated support system for hereditary cancer and its impact on gynecologic services. Int J Clin Oncol (2013) 0.75
[Effect of weekly paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide as neoadjuvant treatment for patients with triple-negative and luminal-type breast cancer - a multicenter study]. Gan To Kagaku Ryoho (2015) 0.75
[Exploration of the Factors Influencing Multi-Drug Cancer Chemotherapy in the Elderly - A Retrospective Study]. Gan To Kagaku Ryoho (2016) 0.75
[The survey for anti-emetic guideline by using questioner]. Gan To Kagaku Ryoho (2015) 0.75
[A successful treatment of progressive necrotizing myositis caused by Aeromonas veronii biotype sobria]. Kansenshogaku Zasshi (2003) 0.75
[Registration of hematological disorders by the Kyushu Hematology Organization for Treatment (K-HOT) Study Group]. Rinsho Ketsueki (2004) 0.75
Simultaneous determination of cytosine arabinoside and its metabolite, uracil arabinoside, in human plasma using hydrophilic interaction liquid chromatography with UV detection. Biomed Chromatogr (2013) 0.75
[Infection control for the treatment of hematological malignancies: a survey of the Kyushu Hematology Organization for Treatment Study Group (K-HOT)]. Rinsho Ketsueki (2003) 0.75
Efficacy and safety of doripenem for sepsis with neutropenia in Japanese patients with hematologic diseases. Jpn J Antibiot (2012) 0.75
Phase I study of the combination of irinotecan hydrochloride, carboplatin, and dexamethasone for the treatment of relapsed or refractory malignant lymphoma. Int J Hematol (2004) 0.75
Bone marrow necrosis in a patient with acute promyelocytic leukemia during re-induction therapy with arsenic trioxide. Eur J Haematol (2004) 0.75
[A case of acute respiratory distress syndrome caused by cryptococcus and cytomegalovirus co-infection after Cushing's syndrome treatment]. Kansenshogaku Zasshi (2013) 0.75